Bisphosphonates in breast cancer radiotherapy: associations with skeletal complications and treatment outcomes - a retrospective cohort study
These findings likely reflect baseline skeletal fragility rather than a direct harmful effect of BPs. BPs remain an important indicator of bone vulnerability rather than a therapeutic modifier.
Authors
- Mohamad Nassereddine (ORCID: https://orcid.org/0000-0002-9487-3042)
- Rawad Lakkis
- Jeffrey Yammine
- Souad Susan Sawaf
- Bshara Sleem (ORCID: https://orcid.org/0009-0000-2584-0565)
- Khanom Baalbaki
- Maya Hemdanieh (ORCID: https://orcid.org/0000-0001-6739-3759)
- Larry Bodgi
Institutions
- Inserm (FR)
- American University of Beirut Medical Center (LB)
- American University of Beirut (LB)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.3389/fonc.2026.1725699
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00